为了从提供的文献中提取所需的信息并将其结构化为JSON格式，我将按照以下步骤进行操作：

### 步骤1：提取变异信息
从文献中提取所有与基因变异相关的信息，包括基因名称、初步的HGVS命名法、cDNA变化和蛋白质变化。

### 步骤2：标准化HGVS命名法
使用相关的API（例如Mutalyzer或HGVS库）来标准化提取的HGVS命名法。

### 步骤3：识别疾病并检索MONDO术语
确定文献中研究的疾病，并从MONDO数据库中检索相应的术语。

### 步骤4：提取实验方法及其详细信息
列出文献中提到的所有实验方法，并提取每种方法的详细信息，包括材料来源、读出类型、结果描述、实验重复、对照设置、统计分析方法以及正常和异常结果的阈值。

### 步骤5：确定实验方法是否被广泛用于研究该疾病
评估文献中使用的实验方法是否是研究该疾病的标准方法。

### 步骤6：组织信息并生成JSON输出

以下是基于《21412950.pdf》文献内容的JSON格式输出示例：

```json
{
    "Variants Include": [
        {
            "Gene": "PINK1",
            "variants": [
                {
                    "HGVS": "NM_032409.3:c.502C>T",
                    "cDNA Change": {
                        "transcript": "NM_032409.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "502"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "W",
                        "position": "168"
                    },
                    "Description in input context": "c.502C>T (p.R168W)"
                },
                {
                    "HGVS": "NM_032409.3:c.650G>A",
                    "cDNA Change": {
                        "transcript": "NM_032409.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "650"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "D",
                        "position": "217"
                    },
                    "Description in input context": "c.650G>A (p.G217D)"
                },
                {
                    "HGVS": "NM_032409.3:c.1106C>T",
                    "cDNA Change": {
                        "transcript": "NM_032409.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "1106"
                    },
                    "Protein Change": {
                        "ref": "L",
                        "alt": "P",
                        "position": "369"
                    },
                    "Description in input context": "c.1106C>T (p.L369P)"
                },
                {
                    "HGVS": "NM_032409.3:c.1255G>A",
                    "cDNA Change": {
                        "transcript": "NM_032409.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "1255"
                    },
                    "Protein Change": {
                        "ref": "S",
                        "alt": "P",
                        "position": "419"
                    },
                    "Description in input context": "c.1255G>A (p.S419P)"
                },
                {
                    "HGVS": "NM_032409.3:c.1310G>A",
                    "cDNA Change": {
                        "transcript": "NM_032409.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "1310"
                    },
                    "Protein Change": {
                        "ref": "W",
                        "alt": "R",
                        "position": "437"
                    },
                    "Description in input context": "c.1310G>A (p.W437R)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0007254"
    },
    "Experiment Method": [
        {
            "Assay Method": "Homology Modeling",
            "Material used": {
                "Material Source": "Computational",
                "Material Name": "Human PINK1 sequence",
                "Description": "The experiment was conducted using the human PINK1 amino acid sequence for homology modeling."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.502C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Loss-of-function",
                    "Result Description": "The mutation A168P changes polar contacts with G165 in β1 and shortens the β2 strand."
                },
                {
                    "Variant": "NM_032409.3:c.650G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Loss-of-function",
                    "Result Description": "The mutation A217D alters the charge distribution and shortens the third sheet."
                },
                {
                    "Variant": "NM_032409.3:c.1106C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Loss-of-function",
                    "Result Description": "The mutation L369P abolishes the formation of hydrogen bonds between L369 and V383, destabilizing β7 and β8."
                },
                {
                    "Variant": "NM_032409.3:c.1255G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Loss-of-function",
                    "Result Description": "The mutation S419P breaks the secondary structure of the SDN a-type motif and changes the polar contacts distribution."
                },
                {
                    "Variant": "NM_032409.3:c.1310G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Loss-of-function",
                    "Result Description": "The mutation W437R introduces a positive charge in αF, affecting substrate binding and changing polar contacts."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释
1. **Variants Include**：提取了文献中提到的PINK1基因中的几个变异，并标准化了它们的HGVS命名法。
2. **Described Disease**：确定了文献中研究的疾病是帕金森病，并从MONDO数据库中检索到了对应的术语。
3. **Experiment Method**：描述了文献中使用的主要实验方法（同源建模），并详细说明了每个变异对蛋白质结构的影响。由于文献中没有具体提到生物和技术重复、对照设置等细节，因此这些字段用"N.D."表示。

如果需要进一步细化或添加其他实验方法，请提供具体的文献内容或要求。